| Year |
Citation |
Score |
| 2023 |
Imig JD. Bioactive lipids in hypertension. Advances in Pharmacology (San Diego, Calif.). 97: 1-35. PMID 37236756 DOI: 10.1016/bs.apha.2023.01.001 |
0.314 |
|
| 2023 |
Imig JD, Khan MAH, Stavniichuk A, Jankiewicz WK, Goorani S, Yeboah MM, El-Meanawy A. Salt-sensitive hypertension after reversal of unilateral ureteral obstruction. Biochemical Pharmacology. 210: 115438. PMID 36716827 DOI: 10.1016/j.bcp.2023.115438 |
0.367 |
|
| 2022 |
Imig JD. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury. Advances in Pharmacology (San Diego, Calif.). 94: 27-55. PMID 35659375 DOI: 10.1016/bs.apha.2022.02.004 |
0.397 |
|
| 2022 |
Baranowska I, Gawrys O, Walkowska A, Olszynski KH, Červenka L, Falck JR, Adebesin AM, Imig JD, Kompanowska-Jezierska E. Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats. Frontiers in Pharmacology. 12: 798642. PMID 35111064 DOI: 10.3389/fphar.2021.798642 |
0.389 |
|
| 2021 |
Jankiewicz WK, Barnett SD, Stavniichuk A, Hwang SH, Hammock BD, Belayet JB, Khan AH, Imig JD. Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity. Frontiers in Pharmacology. 12: 744776. PMID 34955823 DOI: 10.3389/fphar.2021.744776 |
0.328 |
|
| 2021 |
Walkowska A, Červenka L, Imig JD, Falck JR, Sadowski J, Kompanowska-Jezierska E. Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats. Frontiers in Physiology. 12: 622882. PMID 33584348 DOI: 10.3389/fphys.2021.622882 |
0.466 |
|
| 2020 |
Stavniichuk A, Savchuk O, Khan AH, Jankiewicz WK, Imig JD, Merk D. THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODEL. Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia. 80: 10-15. PMID 33437972 DOI: 10.17721/1728_2748.2020.80.10-15 |
0.358 |
|
| 2020 |
Stavniichuk A, Savchuk O, Khan AH, Jankiewicz WK, Imig JD. A SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE. Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia. 81: 25-31. PMID 33251532 DOI: 10.17721/1728_2748.2020.81.25-31 |
0.371 |
|
| 2020 |
Stavniichuk A, Hye Khan MA, Yeboah MM, Chesnik MA, Jankiewicz WK, Hartmann M, Blöcher R, Kircher T, Savchuk O, Proschak E, Imig JD. Dual Soluble Epoxide Hydrolase Inhibitor/PPAR-γ Agonist Attenuates Renal Fibrosis. Prostaglandins & Other Lipid Mediators. 106472. PMID 32569747 DOI: 10.1016/J.Prostaglandins.2020.106472 |
0.471 |
|
| 2020 |
Imig JD, Jankiewicz WK, Khan AH. Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture. Hypertension (Dallas, Tex. : 1979). 76: 3-15. PMID 32475311 DOI: 10.1161/Hypertensionaha.120.13898 |
0.396 |
|
| 2020 |
Gawrys O, Husková Z, Baranowska I, Walkowska A, Sadowski J, Kikerlová S, Vaňourková Z, Honetschlägerová Z, Škaroupková P, Červenka L, Falck JR, Imig JD, Kompanowska-Jezierska E. Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats. Journal of Hypertension. PMID 32384390 DOI: 10.1097/Hjh.0000000000002462 |
0.4 |
|
| 2020 |
Stavniichuk A, Savchuk O, Hye Khan A, Jankiewicz WK, Imig JD, Merk D. The effect of compound DM509 on kidney fibrosis in the conditions of the experimental model Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology. 80: 10-15. DOI: 10.17721/1728_2748.2020.80.10-15 |
0.373 |
|
| 2020 |
Khan MAH, Stavniichuk A, Jankiewicz WK, Vogel AN, Nolan BJ, Savchuk O, Merk D, Imig JD. COMBINED FARNESOID X RECEPTOR AGONIST AND SOLUBLE EPOXIDE HYDROLASE INHIBITOR TREATS PROGRESSIVE RENAL FIBROSIS The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03729 |
0.388 |
|
| 2020 |
Khan MAH, Stavniichuk A, Savchuk O, Jankiewicz WK, Imig JD. REVERSAL OF UNILATERAL URETERAL OBSTRUCTION LEADS TO SALT‐SENSITIVE HYPERTENSION The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03708 |
0.405 |
|
| 2020 |
Jankiewicz WK, Khan MAH, Stavniichuk A, Vogel A, Savchuk O, Hwang SH, Hammock BD, Imig JD. A DUAL COX‐2/sEH INHIBITOR TREATED KIDNEY INJURY IN A DRUG‐INDUCED GLOMERULAR DISEASE MODEL The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03654 |
0.331 |
|
| 2020 |
Palygin O, Khan MAH, Zietara A, Stavniichuk A, Staruschenko A, Imig JD. Fructose Consumption Increases Blood Pressure and Induces Changes in Renal Microvascular Function The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02224 |
0.445 |
|
| 2020 |
Gawrys O, Walkowska A, Kompanowska-Jezierska E, Husková Z, Honetschlägerová Z, Falck J, Imig J, Červenka L. Effective Antihypertensive Treatment with Epoxyeicosatrienoic Acid Analog (EET‐A) and 20‐HETE Antagonist (AAA) of Spontaneously Hypertensive Rats (SHR) The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02103 |
0.417 |
|
| 2019 |
Čertíková Chábová V, Kujal P, Vaňourková Z, Škaroupková P, Sadowski J, Kompanowska-Jezierska E, Tesař V, Hammock B, Imig J, Maxová H, Červenka L, Vaněčková I. Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats. Kidney & Blood Pressure Research. 44: 1493-1505. PMID 31770762 DOI: 10.1159/000504137 |
0.482 |
|
| 2019 |
Imig JD. Epoxyeicosanoids in hypertension. Physiological Research. 68: 695-704. PMID 31475560 DOI: 10.33549/Physiolres.934291 |
0.519 |
|
| 2019 |
Vacková Š, Kikerlová S, Melenovsky V, Kolář F, Imig JD, Kompanowska-Jezierska E, Sadowski J, Červenka L. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure. Kidney & Blood Pressure Research. 1-18. PMID 31430751 DOI: 10.1159/000501688 |
0.494 |
|
| 2019 |
Widiapradja A, Manteufel EJ, Dehlin HM, Pena J, Goldspink PH, Sharma A, Kolb LL, Imig JD, Janicki JS, Lu B, Levick SP. Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart. Scientific Reports. 9: 11004. PMID 31358823 DOI: 10.1038/S41598-019-47369-0 |
0.318 |
|
| 2019 |
Hye Khan MA, Stavniichuk A, Sattar MA, Falck JR, Imig JD. Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice. Frontiers in Pharmacology. 10: 512. PMID 31133860 DOI: 10.3389/Fphar.2019.00512 |
0.454 |
|
| 2019 |
Neckář J, Hye Khan MA, Gross GJ, Cyprová M, Hrdlička J, Kvasilová A, Falck JR, Campbell WB, Sedláková L, Škutová Š, Olejníčková V, Gregorovičová M, Sedmera D, Kolář F, Imig JD. Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats. Clinical Science (London, England : 1979). PMID 30979784 DOI: 10.1042/Cs20180728 |
0.359 |
|
| 2019 |
Hrdlička J, Neckář J, Papoušek F, Husková Z, Kikerlová S, Vaňourková Z, Vernerová Z, Akat F, Vašinová J, Hammock BD, Hwang SH, Imig JD, Falck JR, Červenka L, Kolář F. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Transgenic Rats. Frontiers in Pharmacology. 10: 159. PMID 30881303 DOI: 10.3389/Fphar.2019.00159 |
0.373 |
|
| 2019 |
Vacková Š, Kopkan L, Kikerlová S, Husková Z, Sadowski J, Kompanowska-Jezierska E, Hammock BD, Imig JD, Táborský M, Melenovský V, Červenka L. Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats. Frontiers in Pharmacology. 10: 18. PMID 30728778 DOI: 10.3389/Fphar.2019.00018 |
0.444 |
|
| 2018 |
Miller BS, Blumenthal SR, Shalygin A, Wright KD, Staruschenko A, Imig JD, Sorokin A. Inactivation of p66Shc Decreases Afferent Arteriolar K Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats. Diabetes. PMID 30131395 DOI: 10.2337/Db18-0308 |
0.373 |
|
| 2018 |
Sedláková L, Kikerlová S, Husková Z, Červenková L, Čertíková Chábová V, Zicha J, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Krátký V, Červenka L, Kopkan L. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats. Bioscience Reports. PMID 30054426 DOI: 10.1042/Bsr20171496 |
0.484 |
|
| 2018 |
Imig JD. Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics. Pharmacology & Therapeutics. PMID 29964123 DOI: 10.1016/J.Pharmthera.2018.06.015 |
0.36 |
|
| 2018 |
Červenka L, Husková Z, Kopkan L, Kikerlová S, Sedláková L, Vaňourková Z, Alánová P, Kolář F, Hammock BD, Hwang SH, Imig JD, Falck JR, Sadowski J, Kompanowska-Jezierska E, Neckář J. Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension. Journal of Hypertension. PMID 29570510 DOI: 10.1097/Hjh.0000000000001708 |
0.475 |
|
| 2018 |
Čertíková Chábová V, Kujal P, Škaroupková P, Varňourková Z, Vacková Š, Husková Z, Kikerlová S, Sadowski J, Kompanowska-Jezierska E, Baranowska I, Hwang SH, Hammock BD, Imig JD, Tesař V, Červenka L. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney & Blood Pressure Research. 43: 329-349. PMID 29529602 DOI: 10.1159/000487902 |
0.514 |
|
| 2018 |
Kala P, Sedláková L, Škaroupková P, Kopkan L, Vaňourková Z, Táborský M, Nishiyama A, Hwang SH, Hammock BD, Sadowski J, Melenovský V, Imig JD, Červenka L. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Physiological Research. PMID 29527914 DOI: 10.33549/Physiolres.933757 |
0.468 |
|
| 2018 |
Yeboah MM, Hye Khan MA, Chesnik MA, Skibba M, Kolb LL, Imig JD. Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29361048 DOI: 10.1093/ndt/gfx354 |
0.336 |
|
| 2018 |
Certikova Chabova V, Kujal P, Skaroupkova P, Vanourkova Z, Kopkan L, Huskova Z, Sedlakova L, Sadowski J, Kompanowska-Jezierska E, Hwang S, Hammock B, Imig J, Cervenka L. SP074SOLUBLE EPOXIDE HYDROLASE INHIBITION AUGMENTS RAS BLOCKADE RENOPROTECTION INSUBTOTALLY NEPHRECTOMIZED REN-2 TRANSGENIC HYPERTENSIVE RATS WITH CHRONIC KIDNEY DISEASE Nephrology Dialysis Transplantation. 33: i370-i370. DOI: 10.1093/Ndt/Gfy104.Sp074 |
0.418 |
|
| 2017 |
Campbell WB, Imig JD, Schmitz JM, Falck JR. Orally Active Epoxyeicosatrienoic Acid Analogs. Journal of Cardiovascular Pharmacology. PMID 28937442 DOI: 10.1097/Fjc.0000000000000523 |
0.498 |
|
| 2017 |
Bettaieb A, Koike S, Hsu MF, Ito Y, Chahed S, Bachaalany S, Gruzdev A, Calvo-Rubio M, Lee KSS, Inceoglu B, Imig JD, Villalba JM, Zeldin DC, Hammock BD, Haj FG. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia. Biochimica Et Biophysica Acta. PMID 28757338 DOI: 10.1016/J.Bbagen.2017.07.021 |
0.45 |
|
| 2017 |
Skibba M, Hye Khan MA, Kolb LL, Yeboah MM, Falck JR, Amaradhi R, Imig JD. Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition. Frontiers in Pharmacology. 8: 406. PMID 28713267 DOI: 10.3389/Fphar.2017.00406 |
0.47 |
|
| 2016 |
Imig JD. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Advances in Pharmacology (San Diego, Calif.). 77: 105-41. PMID 27451096 DOI: 10.1016/Bs.Apha.2016.04.003 |
0.329 |
|
| 2016 |
Khan MA, Hwang SH, Sharma A, Corbett JA, Hammock BD, Imig JD. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins & Other Lipid Mediators. PMID 27432695 DOI: 10.1016/J.Prostaglandins.2016.07.003 |
0.413 |
|
| 2016 |
Jíchová Š, Kopkan L, Husková Z, Doleželová Š, Neckář J, Kujal P, Vernerová Z, Kramer HJ, Sadowski J, Kompanowska-Jezierska E, Reddy RN, Falck JR, Imig JD, Červenka L. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats. Journal of Hypertension. PMID 27428043 DOI: 10.1097/Hjh.0000000000001029 |
0.447 |
|
| 2016 |
Yeboah MM, Khan MA, Chesnik MA, Sharma A, Paudyal MP, Falck JR, Imig JD. The Epoxyeicosatrienoic Acid Analog, PVPA, Ameliorates Cyclosporine-Induced Hypertension and Renal Injury in Rats. American Journal of Physiology. Renal Physiology. ajprenal.00288.2016. PMID 27358055 DOI: 10.1152/Ajprenal.00288.2016 |
0.49 |
|
| 2016 |
Miller B, Palygin O, Rufanova VA, Chong A, Lazar J, Jacob HJ, Mattson D, Roman RJ, Williams JM, Cowley AW, Geurts AM, Staruschenko A, Imig JD, Sorokin A. p66Shc regulates renal vascular tone in hypertension-induced nephropathy. The Journal of Clinical Investigation. PMID 27270176 DOI: 10.1172/Jci75079 |
0.512 |
|
| 2016 |
Sharma A, Khan MA, Levick SP, Lee KS, Hammock BD, Imig JD. Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis. International Journal of Molecular Sciences. 17. PMID 27213332 DOI: 10.3390/Ijms17050751 |
0.444 |
|
| 2016 |
Sporková A, Reddy RN, Falck JR, Imig JD, Kopkan L, Sadowski J, Červenka L. Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids. The American Journal of the Medical Sciences. 351: 513-9. PMID 27140711 DOI: 10.1016/J.Amjms.2016.02.030 |
0.531 |
|
| 2016 |
Imig JD, Khan MA, Sharma A, Fish BL, Mandel NS, Cohen E. Radiation-induced Afferent Arteriolar Endothelial-Dependent Dysfunction Involves Decreased Epoxygenase Metabolites. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00023.2016. PMID 27106038 DOI: 10.1152/Ajpheart.00023.2016 |
0.428 |
|
| 2016 |
Imig JD. Renal blood flow autoregulation: what are the contributions for nitric oxide or superoxide to modulate the myogenic response? American Journal of Physiology. Renal Physiology. 310: F1013-5. PMID 26962100 DOI: 10.1152/Ajprenal.00114.2016 |
0.421 |
|
| 2016 |
Khan MA, Fish BL, Wahl G, Sharma A, Falck JR, Paudyal M, Moulder JE, Imig JD, Cohen EP. Epoxyeicosatrienoic acid analog mitigates kidney injury in a rat model of radiation nephropathy. Clinical Science (London, England : 1979). PMID 26772189 DOI: 10.1042/Cs20150778 |
0.496 |
|
| 2015 |
Imig JD, Khan MA. Cytochrome P450 and Lipoxygenase Metabolites on Renal Function. Comprehensive Physiology. 6: 423-41. PMID 26756638 DOI: 10.1002/Cphy.C150009 |
0.448 |
|
| 2015 |
Khan MA, Sharma A, Rarick KR, Roman RJ, Harder DR, Imig JD. Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats. Plos One. 10: e0145335. PMID 26683993 DOI: 10.1371/Journal.Pone.0145335 |
0.375 |
|
| 2015 |
Nayak S, Khan MA, Wan TC, Pei H, Linden J, Dwinell MR, Geurts AM, Imig JD, Auchampach JA. Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension. Purinergic Signalling. PMID 26385692 DOI: 10.1007/S11302-015-9470-7 |
0.434 |
|
| 2015 |
Sullivan JC, Imig JD. Reply to "Letter to the editor: 'Concern regarding quantification of urinary nephrin by commercially available ELISA'". American Journal of Physiology. Renal Physiology. 309: F271. PMID 26357487 DOI: 10.1152/Ajprenal.00239.2015 |
0.356 |
|
| 2015 |
Alánová P, Husková Z, Kopkan L, Sporková A, Jíchová Š, Neckář J, Imig JD, Klevstig M, Kolář F, Rami Reddy N, Falck JR, Sadowski J, Nishiyama A, Kramer HJ, Melenovský V, et al. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. Vascular Pharmacology. 73: 45-56. PMID 26304700 DOI: 10.1016/J.Vph.2015.08.013 |
0.445 |
|
| 2015 |
?ervenka L, Melenovský V, Husková Z, Sporková A, Bürgelová M, Škaroupková P, Hwang SH, Hammock BD, Imig JD, Sadowski J. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula. Physiological Research / Academia Scientiarum Bohemoslovaca. PMID 26047375 DOI: 10.33549/Physiolres.932977 |
0.486 |
|
| 2015 |
Chytilová A, Borchert GH, Mandíková-Alánová P, Hlavá?ková M, Kopkan L, Khan MA, Imig JD, Kolá? F, Necká? J. Tumour necrosis factor-α contributes to improved cardiac ischaemic tolerance in rats adapted to chronic continuous hypoxia. Acta Physiologica (Oxford, England). 214: 97-108. PMID 25760892 DOI: 10.1111/Apha.12489 |
0.306 |
|
| 2015 |
Imig JD. Epoxyeicosatrienoic acids, hypertension, and kidney injury. Hypertension. 65: 476-82. PMID 25583156 DOI: 10.1161/Hypertensionaha.114.03585 |
0.487 |
|
| 2015 |
Kim J, Yoon SP, Toews ML, Imig JD, Hwang SH, Hammock BD, Padanilam BJ. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy. American Journal of Physiology. Renal Physiology. 308: F131-9. PMID 25377915 DOI: 10.1152/Ajprenal.00531.2014 |
0.413 |
|
| 2015 |
Gangadhariah MH, Luther JM, Garcia V, Paueksakon P, Zhang MZ, Hayward SW, Love HD, Falck JR, Manthati VL, Imig JD, Schwartzman ML, Zent R, Capdevila JH, Pozzi A. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. Journal of the American Society of Nephrology : Jasn. 26: 597-610. PMID 25071086 DOI: 10.1681/Asn.2013090980 |
0.464 |
|
| 2014 |
Khan AH, Falck JR, Manthati VL, Campbell WB, Imig JD. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Frontiers in Pharmacology. 5: 216. PMID 25295006 DOI: 10.3389/Fphar.2014.00216 |
0.539 |
|
| 2014 |
Sporková A, Jíchová S, Husková Z, Kopkan L, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Cervenka L. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats. Clinical and Experimental Pharmacology & Physiology. 41: 1003-13. PMID 25224811 DOI: 10.1111/1440-1681.12310 |
0.461 |
|
| 2014 |
Kim J, Imig JD, Yang J, Hammock BD, Padanilam BJ. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation. American Journal of Physiology. Renal Physiology. 307: F971-80. PMID 25164080 DOI: 10.1152/Ajprenal.00256.2014 |
0.414 |
|
| 2014 |
Falck JR, Koduru SR, Mohapatra S, Manne R, Atcha KR, Atcha R, Manthati VL, Capdevila JH, Christian S, Imig JD, Campbell WB. 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications. Journal of Medicinal Chemistry. 57: 6965-72. PMID 25119815 DOI: 10.1021/Jm500262M |
0.322 |
|
| 2014 |
Hye Khan MA, Neckář J, Cummens B, Wahl GM, Imig JD. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 28: 313-22. PMID 24842561 DOI: 10.1007/S10557-014-6530-0 |
0.488 |
|
| 2014 |
Hye Khan MA, Pavlov TS, Christain SV, Neckář J, Staruschenko A, Gauthier KM, Capdevila JH, Falck JR, Campbell WB, Imig JD. Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition. Clinical Science (London, England : 1979). 127: 463-74. PMID 24707975 DOI: 10.1042/Cs20130479 |
0.475 |
|
| 2014 |
Hye Khan MA, Neckář J, Haines J, Imig JD. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats. American Journal of Hypertension. 27: 1087-95. PMID 24598210 DOI: 10.1093/Ajh/Hpu016 |
0.388 |
|
| 2014 |
Kujal P, ?ertíková Chábová V, Škaroupková P, Husková Z, Vernerová Z, Kramer HJ, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Kitada K, Nishiyama A, Hwang SH, Hammock BD, Imig JD, ?ervenka L. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clinical and Experimental Pharmacology & Physiology. 41: 227-37. PMID 24471737 DOI: 10.1111/1440-1681.12204 |
0.517 |
|
| 2014 |
Capdevila JH, Pidkovka N, Mei S, Gong Y, Falck JR, Imig JD, Harris RC, Wang W. The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt. The Journal of Biological Chemistry. 289: 4377-86. PMID 24368771 DOI: 10.1074/Jbc.M113.508416 |
0.461 |
|
| 2014 |
Mohamed IN, Hafez SS, Fairaq A, Ergul A, Imig JD, El-Remessy AB. Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 57: 413-23. PMID 24201577 DOI: 10.1007/S00125-013-3101-Z |
0.321 |
|
| 2013 |
Nagasawa T, Imig JD. Afferent Arteriolar Responses to β,γ-methylene ATP and 20-HETE are not Blocked by ENaC Inhibition. Physiological Reports. 1: e00082. PMID 24159379 DOI: 10.1002/Phy2.82 |
0.334 |
|
| 2013 |
Hye Khan MA, Neckár J, Manthati V, Errabelli R, Pavlov TS, Staruschenko A, Falck JR, Imig JD. Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat. Hypertension. 62: 905-13. PMID 23980070 DOI: 10.1161/Hypertensionaha.113.01949 |
0.479 |
|
| 2013 |
Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Comprehensive Physiology. 3: 957-76. PMID 23720336 DOI: 10.1002/Cphy.C120028 |
0.37 |
|
| 2013 |
Ulu A, Harris TR, Morisseau C, Miyabe C, Inoue H, Schuster G, Dong H, Iosif AM, Liu JY, Weiss RH, Chiamvimonvat N, Imig JD, Hammock BD. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension. Journal of Cardiovascular Pharmacology. 62: 285-97. PMID 23676336 DOI: 10.1097/Fjc.0B013E318298E460 |
0.485 |
|
| 2013 |
Khan MA, Liu J, Kumar G, Skapek SX, Falck JR, Imig JD. Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2946-56. PMID 23603837 DOI: 10.1096/Fj.12-218040 |
0.429 |
|
| 2013 |
Imig JD. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. Prostaglandins & Other Lipid Mediators. 104: 2-7. PMID 23333581 DOI: 10.1016/J.Prostaglandins.2013.01.002 |
0.494 |
|
| 2013 |
Honetschlägerová Z, Kitada K, Husková Z, Sporková A, Kopkan L, Bürgelová M, Varcabová Š, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kramer HJ, Kujal P, Vernerová Z, ?ervenka L. Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME. Journal of Hypertension. 31: 321-32. PMID 23307303 DOI: 10.1097/Hjh.0B013E32835B50Aa |
0.407 |
|
| 2013 |
Varcabova S, Huskova Z, Kramer HJ, Hwang SH, Hammock BD, Imig JD, Kitada K, Cervenka L. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system. Clinical and Experimental Pharmacology & Physiology. 40: 273-81. PMID 23039246 DOI: 10.1111/1440-1681.12018 |
0.529 |
|
| 2013 |
Sorokin A, Miller B, Geurts AM, Imig JD. ET-1-induced contraction of renal afferent arterioles of Dahl salt-sensitive rats is impaired by targeted modification of a p66 Shc regulatory phosphorylation site Life Sciences. 93: e15. DOI: 10.1016/J.Lfs.2013.12.071 |
0.397 |
|
| 2012 |
Imig JD, Walsh KA, Hye Khan MA, Nagasawa T, Cherian-Shaw M, Shaw SM, Hammock BD. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Experimental Biology and Medicine (Maywood, N.J.). 237: 1402-12. PMID 23354399 DOI: 10.1258/Ebm.2012.012225 |
0.46 |
|
| 2012 |
Kopkan L, Husková Z, Sporková A, Varcabová Š, Honetschlägerová Z, Hwang SH, Tsai HJ, Hammock BD, Imig JD, Kramer HJ, Bürgelová M, Vojtíšková A, Kujal P, Vernerová Z, Červenka L. Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension. Kidney & Blood Pressure Research. 35: 595-607. PMID 22948718 DOI: 10.1159/000339883 |
0.508 |
|
| 2012 |
Nagasawa T, Hye Khan MA, Imig JD. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clinical and Experimental Pharmacology & Physiology. 39: 454-61. PMID 22443474 DOI: 10.1111/J.1440-1681.2012.05699.X |
0.484 |
|
| 2012 |
Neckár J, Kopkan L, Husková Z, Kolář F, Papoušek F, Kramer HJ, Hwang SH, Hammock BD, Imig JD, Malý J, Netuka I, Ošťádal B, Červenka L. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-I-ylureido)cyclohexyloxy] benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension Clinical Science. 122: 513-525. PMID 22324471 DOI: 10.1042/Cs20110622 |
0.468 |
|
| 2012 |
Bukhari IA, Shah AJ, Gauthier KM, Walsh KA, Koduru SR, Imig JD, Falck JR, Campbell WB. 11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1574-83. PMID 22307677 DOI: 10.1152/Ajpheart.01122.2011 |
0.324 |
|
| 2012 |
Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiological Reviews. 92: 101-30. PMID 22298653 DOI: 10.1152/Physrev.00021.2011 |
0.334 |
|
| 2012 |
Imig JD, Gabriel Navar L. Measurement of Renal Tubular Angiotensin II. Methods in Molecular Medicine. 51: 427-34. PMID 21331734 DOI: 10.1385/1-59259-087-X:427 |
0.422 |
|
| 2011 |
Elmarakby AA, Faulkner J, Al-Shabrawey M, Wang MH, Maddipati KR, Imig JD. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 301: R1307-17. PMID 21832210 DOI: 10.1152/Ajpregu.00759.2010 |
0.376 |
|
| 2011 |
Zhao X, Zhang Y, Li L, Mann D, Imig JD, Emmett N, Gibbons G, Jin LM. Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy. American Journal of Nephrology. 34: 268-80. PMID 21822010 DOI: 10.1159/000330187 |
0.399 |
|
| 2011 |
Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Falck JR, Campbell WB. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. American Journal of Physiology. Renal Physiology. 301: F765-72. PMID 21753077 DOI: 10.1152/Ajprenal.00201.2011 |
0.392 |
|
| 2011 |
Honetschlägerová Z, Sporková A, Kopkan L, Husková Z, Hwang SH, Hammock BD, Imig JD, Kramer HJ, Kujal P, Vernerová Z, Chábová VC, Tesař V, Cervenka L. Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats. Journal of Hypertension. 29: 1590-601. PMID 21720266 DOI: 10.1097/Hjh.0B013E328349062F |
0.503 |
|
| 2011 |
Khan AH, Imig JD. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome. American Journal of Hypertension. 24: 816-21. PMID 21415842 DOI: 10.1038/Ajh.2011.34 |
0.474 |
|
| 2011 |
Sporková A, Kopkan L, Varcabová S, Husková Z, Hwang SH, Hammock BD, Imig JD, Kramer HJ, Červenka L. Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 300: 1468-1475. PMID 21411763 DOI: 10.1152/Ajpregu.00215.2010 |
0.482 |
|
| 2011 |
Imig JD, Simpkins AN, Renic M, Harder DR. Cytochrome P450 eicosanoids and cerebral vascular function. Expert Reviews in Molecular Medicine. 13: e7. PMID 21356152 DOI: 10.1017/S1462399411001773 |
0.677 |
|
| 2011 |
Honetschlägerová Z, Z Husková Z, Vaňourková Z, Sporková A, Kramer HJ, Hwang SH, Tsai HJ, Hammock BD, Imig JD, Červenka L, Kopkan L. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension. The Journal of Physiology. 589: 207-19. PMID 21078594 DOI: 10.1113/Jphysiol.2010.199505 |
0.518 |
|
| 2010 |
Imig JD, Elmarakby A, Nithipatikom K, Wei S, Capdevila JH, Tuniki VR, Sangras B, Anjaiah S, Manthati VL, Sudarshan Reddy D, Falck JR. Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions. Frontiers in Physiology. 1: 157. PMID 21423396 DOI: 10.3389/Fphys.2010.00157 |
0.427 |
|
| 2010 |
Imig JD. 20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension. Hypertension. 56: 822-3. PMID 20837886 DOI: 10.1161/Hypertensionaha.110.156174 |
0.471 |
|
| 2010 |
Pavlov TS, Imig JD, Staruschenko A. Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors. Ppar Research. 2010: 703735. PMID 20613963 DOI: 10.1155/2010/703735 |
0.374 |
|
| 2010 |
Imig JD. Targeting epoxides for organ damage in hypertension. Journal of Cardiovascular Pharmacology. 56: 329-35. PMID 20531214 DOI: 10.1097/Fjc.0B013E3181E96E0C |
0.437 |
|
| 2010 |
Lee CR, Imig JD, Edin ML, Foley J, DeGraff LM, Bradbury JA, Graves JP, Lih FB, Clark J, Myers P, Perrow AL, Lepp AN, Kannon MA, Ronnekleiv OK, Alkayed NJ, et al. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3770-81. PMID 20495177 DOI: 10.1096/Fj.10-160119 |
0.485 |
|
| 2010 |
Sudhahar V, Shaw S, Imig JD. Epoxyeicosatrienoic acid analogs and vascular function. Current Medicinal Chemistry. 17: 1181-90. PMID 20158473 DOI: 10.2174/092986710790827843 |
0.357 |
|
| 2010 |
Certíková Chábová V, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Kujal P, Vernerová Z, Vanourková Z, Kopkan L, Kramer HJ, Falck JR, Imig JD, Hammock BD, Vanecková I, Cervenka L. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. Clinical Science (London, England : 1979). 118: 617-32. PMID 20050826 DOI: 10.1042/Cs20090459 |
0.535 |
|
| 2010 |
Simpkins AN, Rudic RD, Roy S, Tsai HJ, Hammock BD, Imig JD. Soluble epoxide hydrolase inhibition modulates vascular remodeling. American Journal of Physiology. Heart and Circulatory Physiology. 298: H795-806. PMID 20035028 DOI: 10.1152/Ajpheart.00543.2009 |
0.707 |
|
| 2010 |
Walkowska A, Skaroupková P, Husková Z, Vanourková Z, Chábová VC, Tesar V, Kramer HJ, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Cervenka L. Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats. Journal of Hypertension. 28: 582-93. PMID 19940786 DOI: 10.1097/Hjh.0B013E328334Dfd4 |
0.467 |
|
| 2010 |
Knight SF, Yuan J, Roy S, Imig JD. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. American Journal of Physiology. Renal Physiology. 298: F86-94. PMID 19906952 DOI: 10.1152/Ajprenal.00351.2009 |
0.454 |
|
| 2010 |
Elmarakby AA, Imig JD. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clinical Science (London, England : 1979). 118: 291-301. PMID 19728860 DOI: 10.1042/Cs20090395 |
0.421 |
|
| 2010 |
Honetschlagerova Z, Imig J, Hwang S, Hammock B, Cervenka L, Kopkan L. SOLUBLE EPOXIDE HYDROLASE INHIBITION IMPROVES THE RENAL FUNCTION DURING THE DEVELOPMENT OF MALIGNANT HYPERTENSION IN CYP1A1-REN-2 TRANSGENIC RATS: PP.29.172 Journal of Hypertension. 28: e500. DOI: 10.1097/01.Hjh.0000379710.69921.F9 |
0.503 |
|
| 2009 |
Imig JD, Carpenter MA, Shaw S. The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension. Pharmaceuticals (Basel, Switzerland). 2: 217-227. PMID 27713235 DOI: 10.3390/Ph2030217 |
0.532 |
|
| 2009 |
Imig JD. Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation. Hypertension. 54: 1223-5. PMID 19822801 DOI: 10.1161/Hypertensionaha.109.129981 |
0.416 |
|
| 2009 |
Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nature Reviews. Drug Discovery. 8: 794-805. PMID 19794443 DOI: 10.1038/Nrd2875 |
0.328 |
|
| 2009 |
Quigley R, Chakravarty S, Zhao X, Imig JD, Capdevila JH. Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice. Nephron. Physiology. 113: p23-8. PMID 19713718 DOI: 10.1159/000235774 |
0.425 |
|
| 2009 |
Manhiani M, Quigley JE, Knight SF, Tasoobshirazi S, Moore T, Brands MW, Hammock BD, Imig JD. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. American Journal of Physiology. Renal Physiology. 297: F740-8. PMID 19553349 DOI: 10.1152/Ajprenal.00098.2009 |
0.816 |
|
| 2009 |
Simpkins AN, Rudic RD, Schreihofer DA, Roy S, Manhiani M, Tsai HJ, Hammock BD, Imig JD. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection. The American Journal of Pathology. 174: 2086-95. PMID 19435785 DOI: 10.2353/Ajpath.2009.080544 |
0.765 |
|
| 2009 |
Sudhahar V, Shaw S, Imig JD. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries. European Journal of Pharmacology. 607: 143-50. PMID 19326479 DOI: 10.1016/J.Ejphar.2009.02.002 |
0.341 |
|
| 2009 |
Quigley JE, Elmarakby AA, Knight SF, Manhiani MM, Stepp DW, Olearzcyk JJ, Imig JD. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension. Clinical and Experimental Pharmacology & Physiology. 36: 724-8. PMID 19207724 DOI: 10.1111/J.1440-1681.2009.05139.X |
0.777 |
|
| 2009 |
Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, Luria A, Hammock BD, Imig JD. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clinical Science (London, England : 1979). 116: 61-70. PMID 18459944 DOI: 10.1042/Cs20080039 |
0.533 |
|
| 2008 |
Athirakul K, Bradbury JA, Graves JP, DeGraff LM, Ma J, Zhao Y, Couse JF, Quigley R, Harder DR, Zhao X, Imig JD, Pedersen TL, Newman JW, Hammock BD, Conley AJ, et al. Increased blood pressure in mice lacking cytochrome P450 2J5. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 4096-108. PMID 18716027 DOI: 10.1096/Fj.08-114413 |
0.451 |
|
| 2008 |
Chen JK, Chen J, Imig JD, Wei S, Hachey DL, Guthi JS, Falck JR, Capdevila JH, Harris RC. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. The Journal of Biological Chemistry. 283: 24514-24. PMID 18606824 DOI: 10.1074/Jbc.M709873200 |
0.307 |
|
| 2008 |
Imig JD, Dimitropoulou C, Reddy DS, White RE, Falck JR. Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels. Microcirculation (New York, N.Y. : 1994). 15: 137-50. PMID 18260004 DOI: 10.1080/10739680701456960 |
0.373 |
|
| 2008 |
Imig JD. Eicosanoids and renal damage in cardiometabolic syndrome. Expert Opinion On Drug Metabolism & Toxicology. 4: 165-74. PMID 18248310 DOI: 10.1517/17425255.4.2.165 |
0.332 |
|
| 2008 |
Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A, Imig JD. Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension. 51: 352-9. PMID 18158349 DOI: 10.1161/Hypertensionaha.107.099499 |
0.461 |
|
| 2008 |
Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 294: R76-83. PMID 17989143 DOI: 10.1152/Ajpregu.00466.2007 |
0.459 |
|
| 2008 |
Navar LG, Arendshorst WJ, Pallone TL, Inscho EW, Imig JD, Bell PD. The Renal Microcirculation Microcirculation. 550-683. DOI: 10.1016/B978-0-12-374530-9.00015-2 |
0.429 |
|
| 2007 |
Elmarakby AA, Quigley JE, Olearczyk JJ, Sridhar A, Cook AK, Inscho EW, Pollock DM, Imig JD. Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. Hypertension. 50: 1069-76. PMID 17938380 DOI: 10.1161/Hypertensionaha.107.098806 |
0.54 |
|
| 2007 |
Certíková Chábová V, Kramer HJ, Vanecková I, Thumová M, Skaroupková P, Tesar V, Falck JR, Imig JD, Cervenka L. The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats. Kidney & Blood Pressure Research. 30: 335-46. PMID 17785988 DOI: 10.1159/000107710 |
0.489 |
|
| 2007 |
Socha MJ, Manhiani M, Said N, Imig JD, Motamed K. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. The American Journal of Pathology. 171: 1104-12. PMID 17717147 DOI: 10.2353/Ajpath.2007.061273 |
0.815 |
|
| 2007 |
Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D, Gao Y, Chen L, Zhang X, Davis LS, Wei M, Fan X, Carmosino M, Hao C, Imig JD, et al. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. The Journal of Clinical Investigation. 117: 2496-505. PMID 17710229 DOI: 10.1172/Jci29838 |
0.433 |
|
| 2007 |
Knight SF, Imig JD. Obesity, insulin resistance, and renal function. Microcirculation (New York, N.Y. : 1994). 14: 349-62. PMID 17613807 DOI: 10.1080/10739680701283018 |
0.387 |
|
| 2007 |
Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Vascular Pharmacology. 47: 145-59. PMID 17604232 DOI: 10.1016/J.Vph.2007.05.005 |
0.534 |
|
| 2007 |
Capdevila JH, Falck JR, Imig JD. Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. Kidney International. 72: 683-9. PMID 17597703 DOI: 10.1038/Sj.Ki.5002394 |
0.467 |
|
| 2007 |
Manhiani MM, Quigley JE, Socha MJ, Motamed K, Imig JD. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension. Kidney & Blood Pressure Research. 30: 195-202. PMID 17575466 DOI: 10.1159/000104094 |
0.816 |
|
| 2007 |
Kang KT, Sullivan JC, Sasser JM, Imig JD, Pollock JS. Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension. 49: 893-901. PMID 17309950 DOI: 10.1161/01.Hyp.0000259669.40991.1E |
0.423 |
|
| 2007 |
Elmarakby AA, Williams JM, Imig JD, Pollock JS, Pollock DM. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Vascular Pharmacology. 46: 144-51. PMID 17112788 DOI: 10.1016/J.Vph.2006.09.004 |
0.493 |
|
| 2007 |
Socha MJ, Manhiani M, Said N, Imig J, Motamed K. SPARC deficiency ameliorates renal fibrosis and inflammation in Angiotensin hypertension The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A591-D |
0.81 |
|
| 2007 |
Quigley JE, Elmarakby AA, Imig JD. High fat diet induces insulin resistance and heightened renal inflammation in angiotensin II hypertensive rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A504-C |
0.452 |
|
| 2006 |
Imig JD. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. Cardiovascular Drug Reviews. 24: 169-88. PMID 16961727 DOI: 10.1111/J.1527-3466.2006.00169.X |
0.375 |
|
| 2006 |
Olearczyk JJ, Field MB, Kim IH, Morisseau C, Hammock BD, Imig JD. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels. The Journal of Pharmacology and Experimental Therapeutics. 318: 1307-14. PMID 16772540 DOI: 10.1124/Jpet.106.103556 |
0.431 |
|
| 2006 |
Imig JD. Eicosanoids and renal vascular function in diseases. Clinical Science (London, England : 1979). 111: 21-34. PMID 16764555 DOI: 10.1042/Cs20050251 |
0.474 |
|
| 2006 |
Joly E, Seqqat R, Flamion B, Caron N, Michel A, Imig JD, Kramp R. Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 291. PMID 16675634 DOI: 10.1152/Ajpregu.00401.2005 |
0.516 |
|
| 2006 |
Jin L, Ying Z, Hilgers RH, Yin J, Zhao X, Imig JD, Webb RC. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 318: 288-95. PMID 16569756 DOI: 10.1124/Jpet.105.100735 |
0.431 |
|
| 2006 |
Zhao X, Quigley JE, Yuan J, Wang MH, Zhou Y, Imig JD. PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2187-95. PMID 16501022 DOI: 10.1152/Ajpheart.00937.2005 |
0.424 |
|
| 2006 |
Elmarakby AA, Quigley JE, Pollock DM, Imig JD. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension. 47: 557-62. PMID 16415373 DOI: 10.1161/01.Hyp.0000198545.01860.90 |
0.521 |
|
| 2006 |
Jin L, Foss CE, Zhao X, Mills TM, Wang MH, McCluskey LP, Yaddanapud GS, Falck JR, Imig JD, Webb RC. Cytochrome P450 epoxygenases provide a novel mechanism for penile erection. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 539-41. PMID 16415108 DOI: 10.1096/Fj.05-4341Fje |
0.392 |
|
| 2006 |
Lee DL, Sturgis LC, Labazi H, Osborne JB, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. American Journal of Physiology. Heart and Circulatory Physiology. 290: H935-40. PMID 16284237 DOI: 10.1152/Ajpheart.00708.2005 |
0.783 |
|
| 2006 |
Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, Ergul A. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 290: R435-41. PMID 16239374 DOI: 10.1152/Ajpregu.00300.2005 |
0.326 |
|
| 2006 |
Kang K, Sullivan JC, Sasser JM, Imig JD, Pollock JS. O16. NO/cGMP signaling and NOS-dependent H2O2 production maintain vasorelaxation in small arteries from hypertensive rats Nitric Oxide. 14: 5. DOI: 10.1016/J.Niox.2006.04.020 |
0.352 |
|
| 2005 |
Imig JD, Zhao X, Dey A, Shaw M. CYP450, COX-2 and Obesity Related Renal Damage. Toxicology Mechanisms and Methods. 15: 125-36. PMID 20021073 DOI: 10.1080/15376520590918856 |
0.376 |
|
| 2005 |
Dorrance AM, Rupp N, Pollock DM, Newman JW, Hammock BD, Imig JD. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 46: 842-8. PMID 16306811 DOI: 10.1097/01.Fjc.0000189600.74157.6D |
0.409 |
|
| 2005 |
Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension. 46: 975-81. PMID 16157792 DOI: 10.1161/01.Hyp.0000176237.74820.75 |
0.516 |
|
| 2005 |
Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension. 46: 562-8. PMID 16116048 DOI: 10.1161/01.Hyp.0000179584.39937.41 |
0.437 |
|
| 2005 |
Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. American Journal of Physiology. Renal Physiology. 289: F496-503. PMID 16093425 DOI: 10.1152/Ajprenal.00350.2004 |
0.497 |
|
| 2005 |
Williams JM, Zhao X, Wang MH, Imig JD, Pollock DM. Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension. 46: 366-71. PMID 15967866 DOI: 10.1161/01.Hyp.0000172755.25382.Fc |
0.424 |
|
| 2005 |
Fuller AJ, Hauschild BC, Gonzalez-Villalobos R, Awayda MS, Imig JD, Inscho EW, Navar LG. Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells. American Journal of Physiology. Renal Physiology. 289: F760-7. PMID 15942047 DOI: 10.1152/Ajprenal.00422.2004 |
0.319 |
|
| 2005 |
Pollock DM, Jenkins JM, Cook AK, Imig JD, Inscho EW. L-type calcium channels in the renal microcirculatory response to endothelin. American Journal of Physiology. Renal Physiology. 288: F771-7. PMID 15547114 DOI: 10.1152/Ajprenal.00315.2004 |
0.36 |
|
| 2005 |
Zhao X, Dey A, Romanko OP, Stepp DW, Wang MH, Zhou Y, Jin L, Pollock JS, Webb RC, Imig JD. Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 288: R188-96. PMID 15345471 DOI: 10.1152/Ajpregu.00018.2004 |
0.381 |
|
| 2004 |
Dey A, Williams RS, Pollock DM, Stepp DW, Newman JW, Hammock BD, Imig JD. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obesity Research. 12: 1278-89. PMID 15340111 DOI: 10.1038/Oby.2004.162 |
0.391 |
|
| 2004 |
Zhao X, Falck JR, Gopal VR, Inscho EW, Imig JD. P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid. The Journal of Pharmacology and Experimental Therapeutics. 311: 1211-7. PMID 15316085 DOI: 10.1124/Jpet.104.070797 |
0.32 |
|
| 2004 |
Dey A, Maric C, Kaesemeyer WH, Zaharis CZ, Stewart J, Pollock JS, Imig JD. Rofecoxib decreases renal injury in obese Zucker rats. Clinical Science (London, England : 1979). 107: 561-70. PMID 15307815 DOI: 10.1042/Cs20040125 |
0.415 |
|
| 2004 |
Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Renal autoregulation in P2X1 knockout mice Acta Physiologica Scandinavica. 181: 445-453. PMID 15283757 DOI: 10.1111/J.1365-201X.2004.01317.X |
0.349 |
|
| 2004 |
Imig JD. 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis? American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 287: R3-5. PMID 15191921 DOI: 10.1152/Ajpregu.00151.2004 |
0.419 |
|
| 2004 |
Inscho EW, Cook AK, Murzynowski JB, Imig JD. Elevated arterial pressure impairs autoregulation independently of AT 1 receptor activation Journal of Hypertension. 22: 811-818. PMID 15126924 DOI: 10.1097/00004872-200404000-00025 |
0.48 |
|
| 2004 |
Zhao X, Yamamoto T, Newman JW, Kim IH, Watanabe T, Hammock BD, Stewart J, Pollock JS, Pollock DM, Imig JD. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. Journal of the American Society of Nephrology : Jasn. 15: 1244-53. PMID 15100364 |
0.476 |
|
| 2004 |
Imig JD. ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement. Hypertension (Dallas, Tex. : 1979). 43: 533-5. PMID 14757781 DOI: 10.1161/01.Hyp.0000118054.86193.Ce |
0.476 |
|
| 2003 |
Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. The Journal of Clinical Investigation. 112: 1895-905. PMID 14679185 DOI: 10.1172/Jci18499 |
0.397 |
|
| 2003 |
Imig JD, Zhao X, Orengo SR, Dipp S, El-Dahr SS. The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin. Peptides. 24: 1141-7. PMID 14612184 DOI: 10.1016/J.Peptides.2003.07.003 |
0.436 |
|
| 2003 |
Yiu SS, Zhao X, Inscho EW, Imig JD. 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. Journal of Lipid Research. 44: 2391-9. PMID 12951362 DOI: 10.1194/Jlr.M300183-Jlr200 |
0.403 |
|
| 2003 |
Wang MH, Smith A, Zhou Y, Chang HH, Lin S, Zhao X, Imig JD, Dorrance AM. Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension. Hypertension. 42: 594-9. PMID 12939236 DOI: 10.1161/01.Hyp.0000090123.55365.Ba |
0.52 |
|
| 2003 |
Zhao X, Pollock DM, Zeldin DC, Imig JD. Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension (Dallas, Tex. : 1979). 42: 775-80. PMID 12900436 DOI: 10.1161/01.Hyp.0000085649.28268.Df |
0.497 |
|
| 2003 |
Zhao X, Imig JD. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Current Drug Metabolism. 4: 73-84. PMID 12570747 DOI: 10.2174/1389200033336892 |
0.344 |
|
| 2003 |
Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation (New York, N.Y. : 1994). 9: 315-28. PMID 12152107 DOI: 10.1038/Sj.Mn.7800145 |
0.501 |
|
| 2002 |
Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD. Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension (Dallas, Tex. : 1979). 41: 709-14. PMID 12623984 DOI: 10.1161/01.Hyp.0000047877.36743.Fa |
0.517 |
|
| 2002 |
Imig JD, Breyer MD, Breyer RM. Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice. American Journal of Physiology. Renal Physiology. 283: F415-22. PMID 12167591 DOI: 10.1152/Ajprenal.00351.2001 |
0.396 |
|
| 2002 |
Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. International Journal of Experimental Diabetes Research. 3: 97-108. PMID 11991202 DOI: 10.1080/15604280214483 |
0.452 |
|
| 2002 |
Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension. 39: 690-4. PMID 11882632 DOI: 10.1161/Hy0202.103788 |
0.511 |
|
| 2002 |
Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension. 39: 116-21. PMID 11799089 DOI: 10.1161/Hy0102.100780 |
0.456 |
|
| 2001 |
Imig JD, Falck JR, Wei S, Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. Journal of Vascular Research. 38: 247-55. PMID 11399897 DOI: 10.1159/000051053 |
0.418 |
|
| 2001 |
Imig JD, Zhao X, Falck JR, Wei S, Capdevila JH. Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid. Journal of Hypertension. 19: 983-92. PMID 11393683 DOI: 10.1097/00004872-200105000-00020 |
0.533 |
|
| 2001 |
Holla VR, Adas F, Imig JD, Zhao X, Price E, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proceedings of the National Academy of Sciences of the United States of America. 98: 5211-6. PMID 11320253 DOI: 10.1073/Pnas.081627898 |
0.37 |
|
| 2001 |
Imig JD. Epoxygenase metabolites. Epithelial and vascular actions. Molecular Biotechnology. 16: 233-51. PMID 11252808 DOI: 10.1385/Mb:16:3:233 |
0.304 |
|
| 2001 |
Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, Burns KD. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney International. 58: 2320-30. PMID 11115066 DOI: 10.1046/J.1523-1755.2000.00416.X |
0.348 |
|
| 2001 |
Imig JD. Eicosanoid regulation of the renal vasculature. American Journal of Physiology. Renal Physiology. 279: F965-81. PMID 11097615 DOI: 10.1152/Ajprenal.2000.279.6.F965 |
0.485 |
|
| 2000 |
Imig JD, Cook AK, Inscho EW. Postglomerular vasoconstriction to angiotensin II and norepinephrine depends on intracellular calcium release General Pharmacology: the Vascular System. 34: 409-415. PMID 11483290 DOI: 10.1016/S0306-3623(01)00078-7 |
0.329 |
|
| 2000 |
Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. American Journal of Hypertension. 13: 810-8. PMID 10933574 DOI: 10.1016/S0895-7061(00)00264-8 |
0.512 |
|
| 2000 |
Navar LG, Ichihara A, Chin SY, Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiologica Scandinavica. 168: 139-47. PMID 10691792 DOI: 10.1046/j.1365-201x.2000.00630.x |
0.384 |
|
| 2000 |
Navar LG, Harrison-Bernard LM, Imig JD, Cervenka L, Mitchell KD. Renal responses to AT1 receptor blockade. American Journal of Hypertension. 13: 45S-54S. PMID 10678288 DOI: 10.1016/S0895-7061(99)00248-4 |
0.485 |
|
| 2000 |
Imig JD, Pham BT, LeBlanc EA, Reddy KM, Falck JR, Inscho EW. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension (Dallas, Tex. : 1979). 35: 307-12. PMID 10642316 DOI: 10.1161/01.Hyp.35.1.307 |
0.389 |
|
| 2000 |
Zhuo JL, Imig JD, Benes E, Raibstein SR, Hammond TG, Navar LG. Flow Cytometric Analysis of At1a Receptor Protein Expression in Renal Cortical Endosomes in Angiotensin Ii-Induced Hypertensive Rats Hypertension. 36: 720-720. DOI: 10.1161/01.Hyp.36.Suppl_1.720-C |
0.467 |
|
| 2000 |
Inscho EW, Imig JD, Navar LG. Nonendothelial paracrine regulation of the renal microcirculation Advances in Organ Biology. 9: 219-233. DOI: 10.1016/S1569-2590(00)09067-4 |
0.417 |
|
| 1999 |
Ichihara A, Imig JD, Navar LG. Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure. Hypertension (Dallas, Tex. : 1979). 34: 843-7. PMID 10523371 DOI: 10.1161/01.Hyp.34.4.843 |
0.413 |
|
| 1999 |
Imig JD, Falck JR, Inscho EW. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. British Journal of Pharmacology. 127: 1399-405. PMID 10455289 DOI: 10.1038/Sj.Bjp.0702662 |
0.44 |
|
| 1999 |
Cervenka L, Harrison-Bernard LM, Dipp S, Primrose G, Imig JD, El-Dahr SS. Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice. Hypertension (Dallas, Tex. : 1979). 34: 176-80. PMID 10454437 DOI: 10.1161/01.Hyp.34.2.176 |
0.319 |
|
| 1999 |
Imig JD, Navar GL, Zou LX, O'Reilly KC, Allen PL, Kaysen JH, Hammond TG, Navar LG. Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. The American Journal of Physiology. 277: F303-11. PMID 10444586 DOI: 10.1152/Ajprenal.1999.277.2.F303 |
0.477 |
|
| 1999 |
Ichihara A, Imig JD, Navar LG. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension. Hypertension (Dallas, Tex. : 1979). 33: 462-6. PMID 9931148 DOI: 10.1161/01.Hyp.33.1.462 |
0.378 |
|
| 1999 |
Imig JD, Inscho EW, Deichmann PC, Reddy KM, Falck JR. Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension (Dallas, Tex. : 1979). 33: 408-13. PMID 9931138 DOI: 10.1161/01.Hyp.33.1.408 |
0.301 |
|
| 1998 |
Ichihara A, Inscho EW, Imig JD, Navar LG. Neuronal nitric oxide synthase modulates rat renal microvascular function. American Journal of Physiology. Renal Physiology. 274: F516-F524. PMID 29591816 DOI: 10.1152/ajprenal.1998.274.3.F516 |
0.317 |
|
| 1998 |
Ichihara A, Imig JD, Inscho EW, Navar LG. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS. American Journal of Physiology. Renal Physiology. 275: F605-F612. PMID 29586176 DOI: 10.1152/Ajprenal.1998.275.4.F605 |
0.401 |
|
| 1998 |
Navar LG, Zou L, Von Thun A, Tarng Wang C, Imig JD, Mitchell KD. Unraveling the Mystery of Goldblatt Hypertension. News in Physiological Sciences : An International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society. 13: 170-176. PMID 11390784 DOI: 10.1152/Physiologyonline.1998.13.4.170 |
0.488 |
|
| 1998 |
Gabriel Navar L, Inscho EW, Imig JD, Mitchell KD. Heterogeneous activation mechanisms in the renal microvasculature Kidney International, Supplement. 54. PMID 9736247 DOI: 10.1046/J.1523-1755.1998.06704.X |
0.32 |
|
| 1998 |
Zou LX, Imig JD, Hymel A, Navar LG. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. American Journal of Hypertension. 11: 570-8. PMID 9633793 DOI: 10.1016/S0895-7061(97)00410-X |
0.419 |
|
| 1998 |
Ichihara A, Imig JD, Inscho EW, Navar LG. Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension. Hypertension (Dallas, Tex. : 1979). 31: 1255-60. PMID 9622138 DOI: 10.1161/01.Hyp.31.6.1255 |
0.425 |
|
| 1998 |
Inscho EW, Cook AK, Mui V, Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction Hypertension. 31: 421-428. PMID 9453339 DOI: 10.1161/01.Hyp.31.1.421 |
0.314 |
|
| 1997 |
Imig JD, Deichmann PC. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. The American Journal of Physiology. 273: F274-82. PMID 9277588 DOI: 10.1152/Ajprenal.1997.273.2.F274 |
0.396 |
|
| 1997 |
Kaye AD, Nossaman BD, Smith DE, Ibrahim IN, Imig JD, Kadowitz PJ. Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed. The American Journal of Physiology. 272: L573-9. PMID 9142927 DOI: 10.1152/Ajplung.1997.272.4.L573 |
0.346 |
|
| 1997 |
Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension (Dallas, Tex. : 1979). 29: 442-9. PMID 9039140 DOI: 10.1161/01.Hyp.29.1.442 |
0.504 |
|
| 1997 |
Inscho EW, Imig JD, Cook AK. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores Hypertension. 29: 222-227. PMID 9039106 DOI: 10.1161/01.Hyp.29.1.222 |
0.326 |
|
| 1996 |
Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD, Lombard JH, Lange AR, Roman RJ. Identification of a putative microvascular oxygen sensor. Circulation Research. 79: 54-61. PMID 8925569 DOI: 10.1161/01.Res.79.1.54 |
0.402 |
|
| 1996 |
Zou LX, Imig JD, von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension (Dallas, Tex. : 1979). 28: 669-77. PMID 8843896 DOI: 10.1161/01.Hyp.28.4.669 |
0.409 |
|
| 1996 |
Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. The American Journal of Physiology. 270: R217-27. PMID 8769805 DOI: 10.1152/Ajpregu.1996.270.1.R217 |
0.438 |
|
| 1996 |
Imig JD, Navar LG. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. The American Journal of Physiology. 271: F87-93. PMID 8760247 DOI: 10.1152/Ajprenal.1996.271.1.F87 |
0.412 |
|
| 1996 |
Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation Physiological Reviews. 76: 425-536. PMID 8618962 DOI: 10.1152/Physrev.1996.76.2.425 |
0.424 |
|
| 1996 |
Zou LX, Hymel A, Imig JD, Navar LG. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension (Dallas, Tex. : 1979). 27: 658-62. PMID 8613220 DOI: 10.1161/01.Hyp.27.3.658 |
0.406 |
|
| 1994 |
Imig JD, Zou AP, Ortiz de Montellano PR, Sui Z, Roman RJ. Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. The American Journal of Physiology. 266: H1879-85. PMID 8203587 DOI: 10.1152/Ajpheart.1994.266.5.H1879 |
0.424 |
|
| 1994 |
Zou AP, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. The American Journal of Physiology. 266: F275-82. PMID 8141328 DOI: 10.1152/Ajprenal.1994.266.2.F275 |
0.458 |
|
| 1994 |
Zou AP, Imig JD, Ortiz de Montellano PR, Sui Z, Falck JR, Roman RJ. Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. The American Journal of Physiology. 266: F934-41. PMID 8023972 DOI: 10.1152/Ajprenal.1994.266.6.F934 |
0.39 |
|
| 1993 |
Gebremedhin D, Ma YH, Imig JD, Harder DR, Roman RJ. Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. Journal of Vascular Research. 30: 53-60. PMID 8435472 DOI: 10.1159/000158975 |
0.499 |
|
| 1993 |
Imig JD, Gebremedhin D, Harder DR, Roman RJ. Modulation of vascular tone in renal microcirculation by erythrocytes: role of EDRF. The American Journal of Physiology. 264: H190-5. PMID 8430846 DOI: 10.1152/Ajpheart.1993.264.1.H190 |
0.425 |
|
| 1993 |
Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450. Hypertension (Dallas, Tex. : 1979). 22: 357-64. PMID 8349328 DOI: 10.1161/01.Hyp.22.3.357 |
0.49 |
|
| 1992 |
Imig JD, Roman RJ. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension (Dallas, Tex. : 1979). 19: 770-4. PMID 1592479 DOI: 10.1161/01.Hyp.19.6.770 |
0.435 |
|
| 1991 |
Imig JD, Anderson GL. Small artery resistance increases during the development of renal hypertension. Hypertension (Dallas, Tex. : 1979). 17: 317-22. PMID 1999362 DOI: 10.1161/01.Hyp.17.3.317 |
0.406 |
|
| Show low-probability matches. |